Metagenomi

Ovid eyes next chapter with CEO transition—Chutes & Ladders

Ovid's Levin set to become chairman as its next CEO stands ready. FDA’s oncology head takes top CDER post. Metagenomi shuffles CEO in reorg. Plus more.

Darren Incorvaia , Zoey Becker Nov 14, 2025 8:30am

Metagenomi sheds 25% of workforce, including CEO

Nov 12, 2025 6:30am

pivot change turnaround direction walk away

Metagenomi axes ALS program after seeing Biogen and Ionis flop

Aug 14, 2024 9:20am

empty stage microphone floor comedy spotlight

Moderna exits Metagenomi gene editing deal worth $3B biobucks

May 1, 2024 4:00pm

Photo of Wall Street street sign with american flags in the background

Metagenomi, Telomir offer double test case for preclinical IPOs

Feb 9, 2024 7:00am

Diverse group of hands holding up US dollar banknotes of various denominations on green background - stock photo

Kyverna raises IPO expectations to almost $300M

Feb 6, 2024 9:46am